Back

Fib-4 and FLI in the classification of metabolically healthy vs unhealthy obese

1 September 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Scores (2) Scores ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Assistant Professor Elisabete Martins

Faculty of Medicine University of Porto, Porto (Portugal)

7 More presentations in this session

Presentation thumbnail
Leukocyte trajectories and cardiovascular events in individuals with and without carotid plaque: a community cohort study
Doctor J. Yang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Cardiovascular-kidney-metabolic syndrome in korean: a nationwide stage-specific epidemiology and risk of major adverse cardiovascular events
Professor W. Pyun (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Validation and comparison of SCORE2-Diabetes and ASCVD score in Japanese patients with diabetes without a history of cardiovascular disease
Doctor Y. Nakamura (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Validation of the pathobiological determinants of atherosclerosis in youth risk score in a Norwegian cohort of young adults
Ms B. Lutterbey (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Epicardial adipose tissue thickness as an early predictor of metabolic syndrome in young women with BMI <30
Doctor A. Erdem (Istanbul, TR)
Abstract Slides Video

Access the full session

Session thumbnail
Scores (2)

The Event

Event poster

ESC Congress 2025

1 September 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Profiles of patients with cardiovascular risk factors and the severity of hepatic steatosis and fibrosis assessed by pulsed ultrasound
thumbnail
Congress Presentation
Integrated cardiovascular assessment program
thumbnail
Congress Presentation
Novel LiverRisk score is associated with adverse outcome in heart failure: insights from the BIOSTAT-CHF study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources